EyePoint Pharmaceuticals Inc (EYPT)

7.195 -0.38 (-5.08%) USD  |  NASDAQ  |  Dec 27, 16:00
7.195 0.00 (0.00%) After-Hours: 20:00
More

EyePoint Pharmaceuticals Gross Profit (Annual): 41.39M for Dec. 31, 2023

Gross Profit (Annual) Chart

View Gross Profit (Annual) for EYPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals Inc 11.30B
NovaBay Pharmaceuticals Inc 7.895M
Palatin Technologies Inc 4.392M
iBio Inc --
Theriva Biologics Inc --